MEDIGENA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIGENA
Largest movements
- Intangible fixed assets -€40,000
down €40,000 (-11.8%), from €339,836 to €299,836
- Receivables within one year -€31,914
down €31,914 (-46.7%), from €68,324 to €36,410
of which Other amounts receivable: -€31,914
- Debts after one year -€45,770
down €45,770 (-11.0%), from €415,006 to €369,236
- Other debts -€29,422
down €29,422 (-58.8%), from €50,000 to €20,578
- Profit (loss) carried forward -€5,940
down €5,940 (-100.0%), from €5,940 to €0
- Gross operating margin -€31,159
down €31,159 (-26.0%), from €120,045 to €88,886
- Depreciation +€8,140
up €8,140 (+16.8%), from €48,583 to €56,723
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €569,190 | €488,155 | -€81,035 | -14.2% |
| Fixed assets | 21/28 | €467,035 | €423,169 | -€43,867 | -9.4% |
| Intangible fixed assets | 21 | €339,836 | €299,836 | -€40,000 | -11.8% |
| Tangible fixed assets | 22/27 | €127,200 | €123,333 | -€3,867 | -3.0% |
| Furniture and vehicles | 24 | €110,410 | €108,301 | -€2,109 | -1.9% |
| Other tangible fixed assets | 26 | €16,789 | €15,032 | -€1,758 | -10.5% |
| Current assets | 29/58 | €102,155 | €64,986 | -€37,169 | -36.4% |
| Amounts receivable within one year | 40/41 | €68,324 | €36,410 | -€31,914 | -46.7% |
| Trade receivables | 40 | €0 | - | = | |
| Other amounts receivable | 41 | €68,324 | €36,410 | -€31,914 | -46.7% |
| Cash at bank and in hand | 54/58 | €33,831 | €28,576 | -€5,255 | -15.5% |
| Total equity and liabilities | 10/49 | €569,190 | €488,155 | -€81,035 | -14.2% |
| Equity | 10/15 | €35,940 | €30,000 | -€5,940 | -16.5% |
| Contributions | 10/11 | €30,000 | €30,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €5,940 | €0 | -€5,940 | -100.0% |
| Amounts payable | 17/49 | €533,250 | €458,155 | -€75,095 | -14.1% |
| Amounts payable after more than one year | 17 | €415,006 | €369,236 | -€45,770 | -11.0% |
| Financial debts | 170/4 | €415,006 | €369,236 | -€45,770 | -11.0% |
| Amounts payable within one year | 42/48 | €111,460 | €82,090 | -€29,370 | -26.4% |
| Current portion of amounts payable after more than one year | 42 | €44,048 | €45,770 | +€1,722 | +3.9% |
| Trade debts | 44 | €17,412 | €15,742 | -€1,670 | -9.6% |
| Suppliers | 440/4 | €17,412 | €15,742 | -€1,670 | -9.6% |
| Taxes, remuneration and social security | 45 | €0 | - | = | |
| Taxes | 450/3 | €0 | - | = | |
| Other amounts payable | 47/48 | €50,000 | €20,578 | -€29,422 | -58.8% |
| Accrued charges and deferred income | 492/3 | €6,784 | €6,829 | +€45 | +0.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €48,583 | €56,723 | +€8,140 | +16.8% |
| Other operating charges | 640/8 | €677 | €530 | -€148 | -21.8% |
| Gross operating margin | 9900 | €120,045 | €88,886 | -€31,159 | -26.0% |
| Operating profit (loss) | 9901 | €70,785 | €31,633 | -€39,152 | -55.3% |
| Financial charges | 65/66B | €16,721 | €17,254 | +€533 | +3.2% |
| Recurring financial charges | 65 | €16,721 | €17,254 | +€533 | +3.2% |
| Profit (loss) for the period before taxes | 9903 | €54,065 | €14,379 | -€39,685 | -73.4% |
| Income taxes | 67/77 | €0 | - | = | |
| Profit (loss) for the period | 9904 | €54,065 | €14,379 | -€39,685 | -73.4% |
| Profit (loss) for the period to be appropriated | 9905 | €54,065 | €14,379 | -€39,685 | -73.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.